A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial
Titel:
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial
Auteur:
Santa-Maria, Cesar A. Bardia, Aditya Blackford, Amanda L. Snyder, Claire Connolly, Roisin M. Fetting, John H. Hayes, Daniel F. Jeter, Stacie C. Miller, Robert S. Nguyen, Anne Quinlan, Katie Rosner, Gary L. Slater, Shannon Storniolo, Anna Maria Wolff, Antonio C. Zorzi, Jane Henry, Nora Lynn Stearns, Vered